Jihong Xu

1.6k total citations
16 papers, 1.4k citations indexed

About

Jihong Xu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jihong Xu has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Jihong Xu's work include Peroxisome Proliferator-Activated Receptors (7 papers), NF-κB Signaling Pathways (7 papers) and Immune Cell Function and Interaction (6 papers). Jihong Xu is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), NF-κB Signaling Pathways (7 papers) and Immune Cell Function and Interaction (6 papers). Jihong Xu collaborates with scholars based in United States and China. Jihong Xu's co-authors include Paul D. Drew, Janet A. Chavis, Michael K. Racke, Paul D. Storer, Gail Wagoner, James C. Douglas, Patrick R. Griffin, Philippe Nuhant, Yongjun Wang and Jin Liu and has published in prestigious journals such as Nature, The Journal of Immunology and Journal of Neurochemistry.

In The Last Decade

Jihong Xu

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihong Xu United States 15 643 575 354 172 158 16 1.4k
Gordon P. Meares United States 24 800 1.2× 387 0.7× 291 0.8× 246 1.4× 167 1.1× 34 1.8k
Silvia Belcredito Italy 12 405 0.6× 230 0.4× 253 0.7× 187 1.1× 109 0.7× 15 1.3k
Laetitia Cartier Switzerland 9 488 0.8× 446 0.8× 311 0.9× 367 2.1× 159 1.0× 9 1.3k
Annette Persson Sweden 12 476 0.7× 347 0.6× 337 1.0× 142 0.8× 173 1.1× 19 1.1k
Zhongji Liao United States 14 656 1.0× 245 0.4× 112 0.3× 232 1.3× 101 0.6× 21 1.6k
Khalil S. Rawji Canada 18 521 0.8× 401 0.7× 779 2.2× 197 1.1× 80 0.5× 26 1.7k
Chandramohan Natarajan United States 12 445 0.7× 288 0.5× 184 0.5× 88 0.5× 125 0.8× 19 1.0k
Pingwei Zhao China 22 527 0.8× 541 0.9× 89 0.3× 126 0.7× 178 1.1× 58 1.8k
Shinya Takami Japan 14 352 0.5× 349 0.6× 544 1.5× 189 1.1× 308 1.9× 21 1.2k
Tinggui Yin United States 19 858 1.3× 363 0.6× 147 0.4× 131 0.8× 387 2.4× 26 1.5k

Countries citing papers authored by Jihong Xu

Since Specialization
Citations

This map shows the geographic impact of Jihong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihong Xu more than expected).

Fields of papers citing papers by Jihong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihong Xu. The network helps show where Jihong Xu may publish in the future.

Co-authorship network of co-authors of Jihong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jihong Xu. A scholar is included among the top collaborators of Jihong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihong Xu. Jihong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hu, Lifang, et al.. (2023). Promoted adsorption performance for sulfide over CuO loaded hydrotalcite. Desalination and Water Treatment. 289. 180–190. 1 indexed citations
2.
Kane, Cynthia J.M., Kevin D. Phelan, James C. Douglas, et al.. (2013). Effects of ethanol on immune response in the brain: region-specific changes in aged mice. Journal of Neuroinflammation. 10(1). 66–66. 38 indexed citations
3.
Kane, Cynthia J.M., Kevin D. Phelan, James C. Douglas, et al.. (2013). Effects of Ethanol on Immune Response in the Brain: Region-Specific Changes in Adolescent Versus Adult Mice. Alcoholism Clinical and Experimental Research. 38(2). 384–391. 118 indexed citations
4.
Xu, Jihong, Gail Wagoner, James C. Douglas, & Paul D. Drew. (2012). β-Lapachone ameliorization of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 254(1-2). 46–54. 17 indexed citations
5.
Solt, Laura A., Pawan Kumar, Philippe Nuhant, et al.. (2011). Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 472(7344). 491–494. 419 indexed citations
6.
Xu, Jihong, Gail Wagoner, James C. Douglas, & Paul D. Drew. (2009). Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. Journal of Leukocyte Biology. 86(2). 401–409. 70 indexed citations
7.
Drew, Paul D., Jihong Xu, & Michael K. Racke. (2008). PPAR‐γ: Therapeutic Potential for Multiple Sclerosis. PPAR Research. 2008(1). 627463–627463. 47 indexed citations
8.
Xu, Jihong, Steven W. Barger, & Paul D. Drew. (2008). The PPAR‐γ Agonist 15‐Deoxy‐Δ12,14‐Prostaglandin J2 Attenuates Microglial Production of IL‐12 Family Cytokines: Potential Relevance to Alzheimer′s Disease. PPAR Research. 2008(1). 349185–349185. 20 indexed citations
9.
Xu, Jihong & Paul D. Drew. (2007). Peroxisome Proliferator-Activated Receptor-γ Agonists Suppress the Production of IL-12 Family Cytokines by Activated Glia. The Journal of Immunology. 178(3). 1904–1913. 82 indexed citations
10.
Xu, Jihong, Michael K. Racke, & Paul D. Drew. (2007). Peroxisome proliferator‐activated receptor‐α agonist fenofibrate regulates IL‐12 family cytokine expression in the CNS: relevance to multiple sclerosis. Journal of Neurochemistry. 103(5). 1801–1810. 68 indexed citations
11.
Xu, Jihong, Janet A. Chavis, Michael K. Racke, & Paul D. Drew. (2006). Peroxisome proliferator-activated receptor-α and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. Journal of Neuroimmunology. 176(1-2). 95–105. 86 indexed citations
12.
Xu, Jihong, Paul D. Storer, Janet A. Chavis, Michael K. Racke, & Paul D. Drew. (2005). Agonists for the peroxisome proliferator‐activated receptor‐α and the retinoid X receptor inhibit inflammatory responses of microglia. Journal of Neuroscience Research. 81(3). 403–411. 126 indexed citations
13.
Storer, Paul D., Jihong Xu, Janet A. Chavis, & Paul D. Drew. (2005). Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: Implications for multiple sclerosis. Journal of Neuroimmunology. 161(1-2). 113–122. 151 indexed citations
14.
Xu, Jihong & Paul D. Drew. (2005). 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology. 171(1-2). 135–144. 101 indexed citations
15.
Drew, Paul D., Paul D. Storer, Jihong Xu, & Janet A. Chavis. (2005). Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Research Reviews. 48(2). 322–327. 29 indexed citations
16.
Storer, Paul D., Jihong Xu, Janet A. Chavis, & Paul D. Drew. (2005). Cyclopentenone prostaglandins PGA2 and 15-deoxy-?12,14 PGJ2 suppress activation of murine microglia and astrocytes: Implications for multiple sclerosis. Journal of Neuroscience Research. 80(1). 66–74. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026